Increased PKN2 and M2-Polarized Macrophages Promote HCT116 Cell Invasion
View abstract on PubMed
Summary
This summary is machine-generated.Protein kinase N2 (PKN2) overexpression and M2-polarized macrophages promote colorectal cancer progression. Both factors enhance cancer cell aggressiveness by activating NF-κB signaling, suggesting PKN2 as an oncogenic factor.
Area Of Science
- Oncology
- Cell Biology
- Immunology
Background
- Colorectal cancer (CRC) is a leading cause of cancer death, characterized by high invasiveness and metastasis.
- Understanding the molecular mechanisms driving CRC progression, including the roles of specific genes and immune cells, is crucial for developing effective therapies.
Purpose Of The Study
- To investigate the oncogenic role of Protein Kinase N2 (PKN2) in colorectal cancer cells.
- To examine the impact of M2-polarized macrophages on the malignant phenotype of colorectal cancer cells.
- To elucidate the underlying signaling pathways, specifically NF-κB, involved in these processes.
Main Methods
- Generated a HCT116 colorectal cancer cell line with PKN2 overexpression.
- Differentiated THP-1 cells into M2-like macrophages.
- Established a co-culture system of HCT116 cells and M2-polarized THP-1 cells to assess phenotypic changes.
Main Results
- PKN2 overexpression significantly increased proliferation, migration, invasion, and reduced apoptosis in HCT116 cells.
- Co-culture with M2-polarized THP-1 cells markedly enhanced the aggressive phenotype of HCT116 cells.
- Both PKN2 overexpression and M2-polarized macrophages elevated NF-κB p65 expression in HCT116 cells.
Conclusions
- PKN2 acts as an oncogenic factor in colorectal cancer, promoting its malignant characteristics.
- M2-polarized macrophages contribute to colorectal cancer progression, likely through the activation of NF-κB signaling.
- Targeting PKN2 and modulating the tumor microenvironment, particularly M2 macrophages, may offer therapeutic strategies for colorectal cancer.

